Personalized medicine in pancreatic cancer: the revolution has begun

Personalized Medicine
Raphaël MaréchalJean-Luc Van Laethem

Abstract

Pancreatic ductal adenocarcinoma carries a dismal prognosis. Both chemotherapy and targeted therapies have been disappointing when administered to unselected populations. Recently, progress has been made in our understanding of the genomic landscape of this cancer which displays remarkable heterogeneity suggesting a reorientation of management and research strategies based on molecular characterization and adapted personalized therapy. Resectable disease offers new opportunities for translational research through functional imaging response evaluation and tumor tissue acquisition before and after neoadjuvant therapy. There is urgent need for clinical trials based on molecular profiling in pancreatic ductal adenocarcinoma. In this review we discuss opportunities and limitations of these new strategies, underlining the importance of tissue acquisition and integration of molecular biomarkers in future molecularly driven clinical trials.

References

Feb 1, 1997·World Journal of Surgery·C SpertiS Pedrazzoli
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Nov 13, 2001·Oncogene·T Crnogorac-JurcevicN R Lemoine
Jul 4, 2002·The American Journal of Gastroenterology·Gavin C Harewood, Maurits J Wiersema
Dec 20, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M P ColemanUNKNOWN EUROCARE Working Group
Mar 19, 2004·The New England Journal of Medicine·John P NeoptolemosUNKNOWN European Study Group for Pancreatic Cancer
Feb 25, 2005·The New England Journal of Medicine·Susumu KobayashiBalázs Halmos
Aug 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Volker HeinemannRalf Wilkowski
Jan 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey R InfanteMichael Goggins
Apr 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Asma SultanaPaula Ghaneh
Mar 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raphaël MaréchalJean-Luc Van Laethem
Jun 29, 2010·Cancer Cell·Barry S TaylorWilliam L Gerald
Sep 15, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Luc Van LaethemKarin Haustermans
Oct 29, 2010·Nature·Peter J CampbellP Andrew Futreal
Oct 29, 2010·Nature·Shinichi YachidaChristine A Iacobuzio-Donahue
Jan 21, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria E ArcilaMarc Ladanyi
May 13, 2011·The New England Journal of Medicine·Thierry ConroyUNKNOWN PRODIGE Intergroup
Aug 4, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-L Van LaethemM Lutz
Oct 5, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel D Von HoffManuel Hidalgo
Jan 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert C DoebeleD Ross Camidge
Jan 21, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Timothy R DonahueHong Wu
Mar 9, 2012·The New England Journal of Medicine·Marco GerlingerCharles Swanton
Oct 30, 2012·Nature·Andrew V BiankinSean M Grimmond
Mar 15, 2013·The New England Journal of Medicine·Sarah-Jane DawsonNitzan Rosenfeld
May 22, 2013·Cancer Metastasis Reviews·Cindy NeuzilletEric Raymond
May 29, 2013·Nature Reviews. Clinical Oncology·Leticia De Mattos-ArrudaJoan Seoane
Aug 3, 2013·British Journal of Cancer·R AlvarezM Hidalgo
Oct 18, 2013·The New England Journal of Medicine·Daniel D Von HoffMarkus F Renschler
Oct 18, 2013·Science Translational Medicine·Francois-Clement BidardJorge S Reis-Filho
Dec 5, 2013·Journal of the National Cancer Institute·William GreenhalfUNKNOWN European Study Group for Pancreatic Cancer

❮ Previous
Next ❯

Citations

Apr 25, 2019·International Journal of Health Care Quality Assurance·Ahmed Otokiti

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
biopsy
imaging techniques

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved